Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

Clement K Chan; Atul Jain; Srinivas R Sadda; Neeta Varshney

Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

Clement K Chan, Atul Jain, Srinivas R Sadda, Neeta Varshney

Ophthalmology

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Investigative Ophthalmology Visual Science
Volume	55
State	Published - Apr 30 2014

Disciplines

Biology
Ophthalmology
Endocrinology, Diabetes, and Metabolism
Anatomy

OpenUrl availability

Full text

Cite this

@article{c982118444f14d2f851a2aabec042979,

title = "Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration",

author = "Chan, {Clement K} and Atul Jain and Sadda, {Srinivas R} and Neeta Varshney",

year = "2014",

month = apr,

day = "30",

language = "American English",

volume = "55",

journal = "Investigative Ophthalmology Visual Science",

}

TY - JOUR

T1 - Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

AU - Chan, Clement K

AU - Jain, Atul

AU - Sadda, Srinivas R

AU - Varshney, Neeta

PY - 2014/4/30

Y1 - 2014/4/30

UR - https://iovs.arvojournals.org/article.aspx?articleid=2269419

M3 - Article

VL - 55

JO - Investigative Ophthalmology Visual Science

JF - Investigative Ophthalmology Visual Science

ER -

Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

Disciplines

OpenUrl availability

Other files and links

Cite this